Harada Hideki, Yamashita Uki, Kurihara Hideyuki, Fukushi Eri, Kawabata Jun, Kamei Yuto
Marine and Highland Bioscience Center, Saga University, 152-1 Shonan-cho, Karatsu, Saga 847-0021, Japan.
Anticancer Res. 2002 Sep-Oct;22(5):2587-90.
In a previous report, we discussed an extract from a marine red alga, Amphiroa zonata, which shows selective cytotoxic activity to human leukemic cells, but no cytotoxicity to normal human dermal fibroblast (HDF) cells in vitro. In this study, we identified palmitic acid, a selective cytotoxic substance from the marine algal extract, and investigated its biological activities. At concentrations ranging from 12.5 to 50 micrograms/ml, palmitic acid shows selective cytotoxicity to human leukemic cells, but no cytotoxicity to normal HDF cells. Furthermore, palmitic acid induces apoptosis in the human leukemic cell line MOLT-4 at 50 micrograms/ml. Palmitic acid also shows in vivo antitumor activity in mice. One molecular target of palmitic acid in tumor cells is DNA topoisomerase I, however, interestingly, it does not affect DNA topoisomerase II, suggesting that palmitic acid may be a lead compound of anticancer drugs.
在之前的一份报告中,我们讨论了一种来自海洋红藻——环带 Amphiroa 的提取物,该提取物在体外对人白血病细胞表现出选择性细胞毒性,但对正常人皮肤成纤维细胞(HDF)无细胞毒性。在本研究中,我们鉴定出了这种海洋藻类提取物中的一种选择性细胞毒性物质——棕榈酸,并研究了其生物学活性。在浓度为 12.5 至 50 微克/毫升的范围内,棕榈酸对人白血病细胞表现出选择性细胞毒性,但对正常 HDF 细胞无细胞毒性。此外,棕榈酸在浓度为 50 微克/毫升时可诱导人白血病细胞系 MOLT - 4 发生凋亡。棕榈酸在小鼠体内也表现出抗肿瘤活性。棕榈酸在肿瘤细胞中的一个分子靶点是 DNA 拓扑异构酶 I,然而,有趣的是,它并不影响 DNA 拓扑异构酶 II,这表明棕榈酸可能是抗癌药物的先导化合物。